Optimal Therapeutic Strategy for Non-small Cell Lung Cancer with Mutated Epidermal Growth Factor Receptor

Although epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have been widely used in non-small cell lung cancer (NSCLC) patients, it is still controversial about how to combine EGFR-TKI with chemotherapy and other targeted drugs. We have made a summary on the current therapeutic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhong SHI, Yun FAN
Formato: Artigo
Idioma:Chinês
Publicado em: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2015-02-01
Colecção:Chinese Journal of Lung Cancer
Assuntos:
Lung neoplasms
EGFR-TKI
Chemotherapy
Bevacizumab
Acesso em linha:http://dx.doi.org/10.3779/j.issn.1009-3419.2015.02.11
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados